Texas Sues Tylenol, Claims Companies Hid Autism Risks - Beritaja
By Jonathan Stempel Reuters
Posted October 28, 2025 10:38 am
2:08
‘No reliable evidence’ that utilizing Tylenol during gestation causing autism, contempt Trump’s claim
The makers of Tylenol, Johnson & Johnson and Kenvue, were sued connected Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug’s links to autism and attraction shortage hyperactivity disorder.
Paxton, a Republican, sued 5 weeks aft Republican President Donald Trump said utilizing Tylenol during gestation could origin autism successful children. Trump is not a doctor, and his declare is unproven and not backed by technological evidence.
Johnson & Johnson sold Tylenol for much than six decades, and its erstwhile Kenvue portion has sold it since 2023 aft being spun off. The symptom reliever is known generically arsenic acetaminophen.
4:27
‘Don’t return Tylenol’: Trump, US wellness officials necktie usage to autism
Kenvue has many times defended Tylenol’s safety, and successful a connection said it would take sides against Paxton’s lawsuit.
“Acetaminophen is the safest symptom reliever action for pregnant women arsenic needed passim their full pregnancy,” Kenvue said. “We are profoundly concerned by the perpetuation of misinformation connected the information of acetaminophen.”
In a abstracted statement, Johnson & Johnson did not remark connected Paxton’s lawsuit, and said Kenvue is responsible for “all authorities and liabilities associated pinch the waste of its over-the-counter products, including Tylenol.”
you are at the end of the news article with the title:
"Texas Sues Tylenol, Claims Companies Hid Autism Risks - Beritaja"
Editor’s Note: If you’re looking for emergency gear, warm clothing, or household essentials to stay prepared, check out the wide range of options available on Amazon.
*This link uses the Amazon SiteStripe affiliate program. We may earn a small commission at no extra cost to you.
Subscribe to Beritaja Weekly
Join our readers and get the latest news every Monday — free in your inbox.